Trade name of Upadacitinib

The original drug Upadacitinib (Upadacitinib) is sold under the trade name Ruifu/RINVOQ in China and under the trade name RINVOQ overseas. It is a drug used to treat rheumatoid arthritis (RA), Psoriatic arthritis(PA), atopic dermatitis (AD), ankylosing spondylitis (AS), giant cell arteritis (GCA), systemic lupus arthritis (SLE), inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC)) autoimmune diseases. The price currently sold domestically is around 3,000 RMB, and the price sold overseas is more than 20,000 RMB.